Engineering the Future of Regenerative Surgery
Advanced regenerative biotechnology, organ perfusion systems, stem cell innovation, and next-generation surgical technologies — engineered to extend human life.
- 12+
- Active research programs
- 4
- Patent families filed
- 9
- Clinical collaborators
- 2030 VISION
- WHOLE-BODY CRYOPRESERVATION PLATFORM FOR NEXT-GENERATION CANCER THERAPY
Six technologies. One vision. Infinite possibilities.
Every Aeternus Sol platform is designed for real-world clinical use, built to meet regulatory standards, and grounded in rigorous scientific and biological evidence.
Organ Perfusion
Advanced organ perfusion systems and proprietary preservation solutions designed to maintain organ viability, extend preservation time, reduce ischemic injury, and enable next-generation ex vivo therapeutic interventions before transplantation.
Regenerative Surgery
Advanced regenerative solutions combining tissue engineering, biological scaffolds, and cellular therapies to restore damaged tissues and improve surgical outcomes.
Stem Cells & Exosomes
Next-generation stem cell and exosome platforms developed to promote tissue regeneration and address fibrosis, ischemic injury, and degenerative diseases.
Organ Support
Innovative extracorporeal liver support systems designed to sustain liver function and provide a bridge to recovery or transplantation.
Surgical AI
Artificial intelligence solutions delivering real-time imaging, decision support, workflow optimization, and intelligent assistance for precision surgery.
Bio-Hardware
Proprietary bioreactors and precision biomedical devices engineered to enable standardized, reproducible, and clinically scalable regenerative technologies.
Tomorrow's medicine will not be discovered—it will be designed...
The future of medicine will not be shaped by a single scientific breakthrough, but by the convergence of biotechnology, regenerative biology, artificial intelligence, and precision surgery within an integrated clinical ecosystem. At Aeternus Sol, we develop technologies that transform living tissues into programmable therapeutic platforms. We are building the scientific and technological foundation for a future in which organs can be preserved, repaired, regenerated, and re-engineered. Our mission extends far beyond treating disease. By seamlessly translating scientific discoveries into clinical innovation, we aim to redefine the boundaries of organ transplantation, tissue regeneration, and surgical innovation through solutions that bridge research and patient care. The next era of medicine will be defined by systems that regenerate rather than replace, restore rather than merely repair, and anticipate clinical challenges instead of simply reacting to them. We are designing and building that future—today.
Extending Life Beyond Time
We are advancing next-generation organ perfusion and preservation technologies designed to prolong organ viability, maintain physiological function, and unlock new possibilities for transplantation, regenerative medicine, and ex vivo therapeutic applications.
Making Regeneration Standardized and Reproducible
We transform innovations in stem cells, exosomes, and tissue engineering into standardized, reliable, reproducible, and clinically ready therapeutic platforms.
Amplifying the Surgeon's Power Through Technology
By integrating artificial intelligence into the operating room, we enhance surgical precision, support decision-making, strengthen patient safety, and develop intelligent systems that complement the surgeon's expertise.
Designing an Integrated Regenerative Ecosystem
By uniting biotechnology, medical devices, software, artificial intelligence, and regenerative sciences within a single integrated platform, we are building the precision medicine infrastructure of the future.
Building the Future of Organ Replacement Technologies
By developing bioengineered organs, extracorporeal organ support systems, and regenerative technologies, we are taking healthcare beyond traditional organ transplantation and opening the path to true biological restoration.
Redefining the Boundaries of Healthy and Extended Life
By exploring the frontiers of organ preservation, metabolic suspension, cryopreservation, and regenerative biotechnology, we develop technologies that reshape lifespan, healing capacity, and the potential for healthy aging.
An Innovation Ecosystem Without Boundaries for the Future of Medicine
Aeternus Sol is building a global platform that brings together visionary researchers, clinicians, engineers, entrepreneurs, and institutions under a shared mission to shape the future of regenerative medicine. Through international collaborations and interdisciplinary partnerships, we accelerate the transformation of groundbreaking scientific ideas into transformative healthcare technologies with global impact.
Building strategic partnerships that connect universities, hospitals, research centers, and biotechnology innovators across the world.
Creating an international environment where scientific expertise, clinical experience, and technological innovation are shared without borders.
Accelerating breakthrough healthcare technologies through multidisciplinary collaboration between academia, healthcare, industry, and entrepreneurs.
Creating an integrated international ecosystem where science, technology, and innovation converge to shape the future of regenerative medicine.
Establishing long-term collaborations with leading institutions worldwide to advance regenerative medicine through shared expertise and collective innovation.
Aeternus Sol Biotech anchors a global ecosystem where regenerative surgery, biotechnology and physician education converge into a single scientific continuum.
Partner with us in building the regenerative century.
For clinicians, scientific collaborators, and strategic investors aligned with the next era of medicine.